newsfilter
← Latest News
PR Newswire·

Mallinckrodt Announces Publication of Phase 3 STRATA2016 Study in Burns

DUBLIN, July 7, 2021 /PRNewswire/ -- Mallinckrodt plc (OTC:MNKKQ), a global biopharmaceutical company, today announced publication of results from the pivotal Phase 3 STRATA2016 clinical trial of StrataGraft® (allogeneic cultured keratinocytes and der